Come up with a name for your new list and we'll add to it:
RadioMedix raised a round of funding on August 27, 2015. Investors include
National Cancer Institute.
RadioMedix is a clinical phase biotechnology company focused on commercialization of innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is interested…